STAT3 as a promising chemoresistance biomarker associated with the CD44 +/high /CD24 -/low /ALDH + BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line-Reference-Cited by-同舟云学术

STAT3 as a promising chemoresistance biomarker associated with the CD44 +/high /CD24 -/low /ALDH + BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line

Published:2018-02 Issue:2 Volume:363 Page:283-290
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Moreira Milene Pereira,da Conceição Braga Letícia,Cassali Geovanni Dantas,Silva Luciana Maria

Funder

FAPEMIG

CAPES

CNPq

Publisher

Elsevier BV

Subject

Cell Biology

Reference69 articles.

1. Cancer Statistics, 2017;Siegel;Ca Cancer J. Clin.,2017

2. Breast cancer stem cells: obstacles to therapy;Smalley;Cancer Lett.,2013

3. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features;Creighton;PNAS,2009

4. Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo;Jia;Oncotarget,2015

5. Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells;Sun;Biomaterials,2016

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplexed sequential imaging in living cells with orthogonal fluorogenic RNA aptamer/dye pairs;Nucleic Acids Research;2024-06-26

2. The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway;Frontiers in Pharmacology;2024-05-09

3. RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities;Critical Reviews in Oncology/Hematology;2024-03

4. Targeting breast cancer stem cells through retinoids: A new hope for treatment;Critical Reviews in Oncology/Hematology;2023-12

5. Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review;Medicine;2023-10-27